FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2067163557> ?p ?o ?g. }

• W2067163557 endingPage "898" @default.
• W2067163557 startingPage "889" @default.
• W2067163557 abstract "Synaptic loss, particularly related to the forebrain cholinergic system, is considered to be an early event that leads to Alzheimer's disease (AD) and has led to the development of acetylcholinesterase inhibitors (AChE-Is) as the mainstay of treatment for several degenerative disorders that culminate in dementia. The primary dose-limiting toxicities of all clinically available AChE-Is are, similar to useful actions on cognition, cholinergically mediated and they ultimately limit the value of this drug class in achieving anything but symptomatic improvements. In addition, AChE levels in brain areas associated with AD decline with disease progression, which likely ultimately limits the therapeutic utility of this drug class. New research indicates that selective inhibition of butyrylcholinesterase (BuChE), a closely related enzyme that is markedly elevated in AD brain, increases acetylcholine (ACh) and augments cognition in rodents free of the characteristic undesirable actions of AChE-Is. BuChE inhibition hence represents an innovative treatment approach for AD, and agents are currently being synthesized to optimally achieve this. The novel compound, tetrahydrofurobenzofuran cymserine (THFBFC), is derived from our effort to produce a potent and BuChE-selective inhibitor as a candidate to test the hypothesis that BuChE-Is would be efficacious and better tolerated than AChE-Is in AD. Herein, we applied innovative enzyme kinetic analyses to characterize the quantitative interaction of THFBFC with human BuChE. These provided values for the agent's IC(50), together with specific new kinetic constants, such as K (T50), K (T1/2), R (I), (o)K (RT), (o)P(max), K(PT) and PT(1/2), to aid define target concentrations for clinical translation. Additional classical kinetic parameters, including K(i), K(m)or K(s), k(cat) or V(max) and V (mi) were also determined. THFBFC proved to be a potent competitive inhibitor of human BuChE and, like its isomer dihydrobenzodioxepine cymserine, is a potentially interesting AD drug candidate." @default.
• W2067163557 created "2016-06-24" @default.
• W2067163557 creator A5001780861 @default.
• W2067163557 creator A5010690390 @default.
• W2067163557 creator A5031854067 @default.
• W2067163557 creator A5033191031 @default.
• W2067163557 creator A5034036358 @default.
• W2067163557 creator A5040140025 @default.
• W2067163557 creator A5056649584 @default.
• W2067163557 creator A5059163678 @default.
• W2067163557 date "2008-01-31" @default.
• W2067163557 modified "2023-09-28" @default.
• W2067163557 title "Tetrahydrofurobenzofuran cymserine, a potent butyrylcholinesterase inhibitor and experimental Alzheimer drug candidate, enzyme kinetic analysis" @default.
• W2067163557 cites W1414467474 @default.
• W2067163557 cites W1541961513 @default.
• W2067163557 cites W1562859000 @default.
• W2067163557 cites W1572510728 @default.
• W2067163557 cites W168715043 @default.
• W2067163557 cites W180469417 @default.
• W2067163557 cites W1948740236 @default.
• W2067163557 cites W1965493575 @default.
• W2067163557 cites W1971048984 @default.
• W2067163557 cites W1983128308 @default.
• W2067163557 cites W1983829653 @default.
• W2067163557 cites W1990854180 @default.
• W2067163557 cites W2001655480 @default.
• W2067163557 cites W2007654265 @default.
• W2067163557 cites W2009524695 @default.
• W2067163557 cites W2011580750 @default.
• W2067163557 cites W2011878446 @default.
• W2067163557 cites W2013221641 @default.
• W2067163557 cites W2017728335 @default.
• W2067163557 cites W2021788330 @default.
• W2067163557 cites W2023064701 @default.
• W2067163557 cites W2027971714 @default.
• W2067163557 cites W2028560703 @default.
• W2067163557 cites W2048006402 @default.
• W2067163557 cites W2054662854 @default.
• W2067163557 cites W2056604025 @default.
• W2067163557 cites W2067105166 @default.
• W2067163557 cites W2070566742 @default.
• W2067163557 cites W2070847811 @default.
• W2067163557 cites W2073436941 @default.
• W2067163557 cites W2074919962 @default.
• W2067163557 cites W2075481535 @default.
• W2067163557 cites W2090663532 @default.
• W2067163557 cites W2096448893 @default.
• W2067163557 cites W2098374631 @default.
• W2067163557 cites W2103126689 @default.
• W2067163557 cites W2111863354 @default.
• W2067163557 cites W2116488337 @default.
• W2067163557 cites W2122429894 @default.
• W2067163557 cites W2144300874 @default.
• W2067163557 cites W2152958765 @default.
• W2067163557 cites W2159866533 @default.
• W2067163557 cites W2162807572 @default.
• W2067163557 cites W2949780776 @default.
• W2067163557 cites W4234060991 @default.
• W2067163557 cites W4293247451 @default.
• W2067163557 doi "https://doi.org/10.1007/s00702-008-0022-y" @default.
• W2067163557 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5193500" @default.
• W2067163557 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18235987" @default.
• W2067163557 hasPublicationYear "2008" @default.
• W2067163557 type Work @default.
• W2067163557 sameAs 2067163557 @default.
• W2067163557 citedByCount "55" @default.
• W2067163557 countsByYear W20671635572012 @default.
• W2067163557 countsByYear W20671635572013 @default.
• W2067163557 countsByYear W20671635572014 @default.
• W2067163557 countsByYear W20671635572015 @default.
• W2067163557 countsByYear W20671635572016 @default.
• W2067163557 countsByYear W20671635572017 @default.
• W2067163557 countsByYear W20671635572018 @default.
• W2067163557 countsByYear W20671635572019 @default.
• W2067163557 countsByYear W20671635572020 @default.
• W2067163557 countsByYear W20671635572022 @default.
• W2067163557 countsByYear W20671635572023 @default.
• W2067163557 crossrefType "journal-article" @default.
• W2067163557 hasAuthorship W2067163557A5001780861 @default.
• W2067163557 hasAuthorship W2067163557A5010690390 @default.
• W2067163557 hasAuthorship W2067163557A5031854067 @default.
• W2067163557 hasAuthorship W2067163557A5033191031 @default.
• W2067163557 hasAuthorship W2067163557A5034036358 @default.
• W2067163557 hasAuthorship W2067163557A5040140025 @default.
• W2067163557 hasAuthorship W2067163557A5056649584 @default.
• W2067163557 hasAuthorship W2067163557A5059163678 @default.
• W2067163557 hasBestOaLocation W20671635572 @default.
• W2067163557 hasConcept C15744967 @default.
• W2067163557 hasConcept C16568411 @default.
• W2067163557 hasConcept C169760540 @default.
• W2067163557 hasConcept C181199279 @default.
• W2067163557 hasConcept C185592680 @default.
• W2067163557 hasConcept C22885893 @default.
• W2067163557 hasConcept C2775910092 @default.
• W2067163557 hasConcept C2778816929 @default.
• W2067163557 hasConcept C2779059548 @default.
• W2067163557 hasConcept C2779101902 @default.
• W2067163557 hasConcept C2780035454 @default.

• next